Skip to main content

Loading market data...

BHC

Bausch Health Companies Inc.

NYSE • United states

$6.45

+$0.13

(+1.98%)

Source: Yahoo Finance · Quote time Oct 20, 2026 17:48 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Bausch Health Companies Inc. (BHC)

Unavailable

Quotes may be delayed

$2.41B

Market Cap

973,326

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

Bausch Health Companies Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

30 Jul 2026

Bausch Health Companies Inc. filed Form 10-Q

Bausch Health Companies Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

29 Jul 2026

Bausch Health Companies Inc. reported Operating or financial results

Bausch Health Companies Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

1 Jul 2026

Bausch Health Companies Inc. reported A director or senior management change or compensation event

Bausch Health Companies Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

19 May 2026

Bausch Health Companies Inc. reported Shareholder voting results

Bausch Health Companies Inc. filed an 8-K covering shareholder voting results.

29 Apr 2026

Bausch Health Companies Inc. filed Form 10-Q

Bausch Health Companies Inc. submitted Form 10-Q to the SEC for the period ending Mar 31, 2026.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$1.83B

Total assets (USD)$24.79B

Total liabilities (USD)$25.60B

Shareholders' equity (USD)−$1.77B

Long-term debt (USD)$19.88B

Debt due within a year (USD)$866.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$2.85B	$740.00M	$258.00M	$0.68	10-Q · 30 Jul 2026
Q1 2026	$2.52B	−$950.00M	−$1.42B	−$3.82	10-Q · 30 Apr 2026
Q4 2025	$2.80B	$474.00M	−$112.00M	Unavailable	10-K · 19 Feb 2026
Q3 2025	$2.68B	$619.00M	$179.00M	$0.48	10-Q · 30 Oct 2025
Q2 2025	$2.53B	$444.00M	$148.00M	$0.40	10-Q · 31 Jul 2025
Q1 2025	$2.26B	$276.00M	−$58.00M	−$0.16	10-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $9.00

39.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

0

⏸️

Hold

1

📉

Sell

0

1 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 17:48 UTC Targets range 9.00–9.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

30

Sep 2026

Paulson John

Director

Grant or award

$5.83 per share

10,720 shares

30

Sep 2026

LEUNG SANDRA

Director

Grant or award

$5.83 per share

5,789 shares

30

Sep 2026

WECHSLER AMY B

Director

Grant or award

$5.83 per share

1,179 shares

19

Aug 2026

Lenar Aimee J.

President, US Pharma

Open-market sale

$7.03 per share

36,827 shares

17

Jul 2026

Lenar Aimee J.

President, US Pharma

Tax withholding

$4.83 per share

5,260 shares

15

Jul 2026

Lenar Aimee J.

President, US Pharma

Tax withholding

$4.89 per share

23,395 shares

14

Jul 2026

LEE STEVEN HYOSIG

SVP, Controller & CAO

Tax withholding

$4.75 per share

3,125 shares

30

Jun 2026

WECHSLER AMY B

Director

Grant or award

$4.93 per share

1,394 shares

Top Shareholders

Paulson & Co. Inc.

73,255,869 shares

0% change

6/30/2026

Goldentree Asset Management Lp

34,665,731 shares

0% change

6/30/2026

Royal Bank Of Canada

10,832,582 shares

-4.672% change

6/30/2026

Vanguard Group Inc

10,679,760 shares

-12.755% change

12/31/2025

Healthcare Of Ontario Pension Plan Trust Fund

8,000,000 shares

0% change

6/30/2026

Vanguard Capital Management Llc

7,465,468 shares

0.833% change

6/30/2026

Goldman Sachs Group Inc

6,225,131 shares

19.531% change

6/30/2026

Mfn Partners Management, Lp

6,000,000 shares

0% change

6/30/2026

Sg Americas Securities, Llc

5,535,771 shares

37278.602% change

6/30/2026

Acadian Asset Management Llc

5,482,986 shares

12.368% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 17:48 UTC· 1 day ago

Research coverage and investment tools

Bausch Health Companies Inc. (BHC) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its last price was US$6.45 on 20 Oct 2026. That is 58% of the way from its 52-week low of US$4.33 to its 52-week high of US$8.00. Its market capitalisation was US$2.41 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$2.85B	$740.00M	$258.00M	$0.68	—	25.9%	$593.00M	10-Q · 30 Jul 2026 (opens in a new tab)
Q1 2026	$2.52B	−$950.00M	−$1.42B	−$3.82	—	-37.6%	$121.00M	10-Q · 30 Apr 2026 (opens in a new tab)
Q4 2025	$2.80B	$474.00M	−$112.00M	Unavailable	—	17.0%	$403.00M	10-K · 19 Feb 2026 (opens in a new tab)
Q3 2025	$2.68B	$619.00M	$179.00M	$0.48	—	23.1%	$314.00M	10-Q · 30 Oct 2025 (opens in a new tab)
Q2 2025	$2.53B	$444.00M	$148.00M	$0.40	—	17.5%	$190.00M	10-Q · 31 Jul 2025 (opens in a new tab)
Q1 2025	$2.26B	$276.00M	−$58.00M	−$0.16	—	12.2%	$96.00M	10-Q · 1 May 2025 (opens in a new tab)

Cash and equivalents: $1.83B
Total assets: $24.79B
Total liabilities: $25.60B
Shareholders' equity: −$1.77B
Long-term debt: $19.88B
Debt due within a year: $866.00M

10-Q · 30 Jul 2026

Bausch Health Companies Inc. filed Form 10-Q (opens in a new tab)

Bausch Health Companies Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 29 Jul 2026

Bausch Health Companies Inc. reported Operating or financial results (opens in a new tab)

Bausch Health Companies Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 1 Jul 2026 · Management change

Bausch Health Companies Inc. reported A director or senior management change or compensation event (opens in a new tab)

Bausch Health Companies Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 19 May 2026

Bausch Health Companies Inc. reported Shareholder voting results (opens in a new tab)

Bausch Health Companies Inc. filed an 8-K covering shareholder voting results.
10-Q · 29 Apr 2026

Bausch Health Companies Inc. filed Form 10-Q (opens in a new tab)

Bausch Health Companies Inc. submitted Form 10-Q to the SEC for the period ending Mar 31, 2026.

Insider	Date	Transaction	Shares	Average price	Filing
Paulson John Director	30 Sep 2026	Grant or award (A)	+10,720	$5.83	Form 4 (opens in a new tab)
LEUNG SANDRA Director	30 Sep 2026	Grant or award (A)	+5,789	$5.83	Form 4 (opens in a new tab)
WECHSLER AMY B Director	30 Sep 2026	Grant or award (A)	+1,179	$5.83	Form 4 (opens in a new tab)
Lenar Aimee J. President, US Pharma	19 Aug 2026	Open-market sale (S)	−36,827	$7.03	Form 4 (opens in a new tab)
Lenar Aimee J. President, US Pharma	17 Jul 2026	Tax withholding (F)	−5,260	$4.83	Form 4 (opens in a new tab)
Lenar Aimee J. President, US Pharma	15 Jul 2026	Tax withholding (F)	−23,395	$4.89	Form 4 (opens in a new tab)
LEE STEVEN HYOSIG SVP, Controller & CAO	14 Jul 2026	Tax withholding (F)	−3,125	$4.75	Form 4 (opens in a new tab)
WECHSLER AMY B Director	30 Jun 2026	Grant or award (A)	+1,394	$4.93	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Paulson & Co. Inc.	6/30/2026	73,255,869	0%
Goldentree Asset Management Lp	6/30/2026	34,665,731	0%
Royal Bank Of Canada	6/30/2026	10,832,582	-4.672%
Vanguard Group Inc	12/31/2025	10,679,760	-12.755%
Healthcare Of Ontario Pension Plan Trust Fund	6/30/2026	8,000,000	0%
Vanguard Capital Management Llc	6/30/2026	7,465,468	0.833%
Goldman Sachs Group Inc	6/30/2026	6,225,131	19.531%
Mfn Partners Management, Lp	6/30/2026	6,000,000	0%
Sg Americas Securities, Llc	6/30/2026	5,535,771	37278.602%
Acadian Asset Management Llc	6/30/2026	5,482,986	12.368%

Previous close: 6.32 USD
Day range: 6.37 – 6.54 USD
52-week range: 4.33 – 8.00 USD
Volume: 973,326
Market cap: $2.41B
Average volume: 4,444,430
EPS (FY 2025, diluted): 0.42 USD
Shares outstanding: 373.99M
Beta (5Y monthly): 0.35

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 17:48 UTC· 1 day ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:25 UTC· 1 hour ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for BHC yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.